Stocks · News reference

8-K filing — VOLITIONRX LTD (VNRX)

Sep 15, 2026, 9:00 PMSEC EDGAR

Filed: 2026-09-15 AccNo: 0001477932-26-005620 Size: 137 KB Item 3.02: Unregistered Sales of Equity Securities

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 14, 2026, 12:20 PMBenzinga Newsdesk
VolitionRx Fully Pays Off $7.5M Convertible Promissory Note, Dated May 20, 2025
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces the full pre-payment in cash of the outstanding balance on its senior secured convertible promissory note, dated
VNRX
BenzingaAug 31, 2026, 11:58 AMBenzinga Newsdesk
VolitionRX shares are trading lower after the company filed a prospectus for an offering of 10 million shares.
VNRX
BenzingaAug 28, 2026, 8:26 PMBenzinga Newsdesk
Volitionrx Files Prospectus For Offering 10M Common Shares On Behalf Of Selling Shareholders
SEC.
VNRX